Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DFTX | Karlin Daniel | Chief Medical Officer | 09/14/2026 | Zuteilung | — | 200,000 | — | Form 4 |
| DFTX | Wiley Matthew T. | Chief Commercial Officer | 09/14/2026 | Zuteilung | — | 125,000 | — | Form 4 |
| DFTX | Sullivan Mark | Chief Legal Officer | 09/14/2026 | Zuteilung | — | 125,000 | — | Form 4 |
| DFTX | Roberts Brandi | Chief Financial Officer | 09/14/2026 | Zuteilung | — | 125,000 | — | Form 4 |
| DFTX | Barrow Robert | Chief Executive Officer | 09/14/2026 | Zuteilung | — | 750,000 | — | Form 4 |
| DFTX | Barrow Robert | Chief Executive Officer | 09/03/2026 | Verkauf | 37.94 | 19,023 | 721,733 | Form 4 |
| DFTX | Barrow Robert | Chief Executive Officer | 09/02/2026 | Zuteilung | — | 40,000 | — | Form 4 |
| DFTX | Barrow Robert | Chief Executive Officer | 08/12/2026 | Zuteilung | — | 375,000 | — | Form 4 |
| DFTX | Karlin Daniel | Chief Medical Officer | 08/12/2026 | Zuteilung | — | 100,000 | — | Form 4 |
| DFTX | Sullivan Mark | Chief Legal Officer | 08/12/2026 | Zuteilung | — | 62,500 | — | Form 4 |
| DFTX | Wiley Matthew T. | Chief Commercial Officer | 08/12/2026 | Zuteilung | — | 62,500 | — | Form 4 |
| DFTX | Roberts Brandi | Chief Financial Officer | 08/12/2026 | Zuteilung | — | 62,500 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).